Cargando…
Healthcare Provider Engagement with a Novel Dashboard for Tracking Medication Ingestion: Impact on Treatment Decisions and Clinical Assessments for Adults with Schizophrenia
PURPOSE: Schizophrenia is a severe, chronic condition accounting for disproportionate healthcare utilization. Antipsychotics can reduce relapse rates, but the characteristics of schizophrenia may hinder medication adherence. A phase 3b open-label clinical trial used aripiprazole tablets with sensor...
Autores principales: | Cochran, Jeffrey M, Fang, Hui, Sonnenberg, John G, Cohen, Elan A, Lindenmayer, Jean-Pierre, Reuteman-Fowler, J Corey |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9343256/ https://www.ncbi.nlm.nih.gov/pubmed/35928793 http://dx.doi.org/10.2147/NDT.S369123 |
Ejemplares similares
-
Participant Engagement and Symptom Improvement: Aripiprazole Tablets with Sensor for the Treatment of Schizophrenia
por: Cochran, Jeffrey M, et al.
Publicado: (2022) -
An Architectural Framework for Healthcare Dashboards Design
por: Rouhani, Saeed, et al.
Publicado: (2021) -
Using Participatory Design to Engage Physicians in the Development of a Provider-Level Performance Dashboard and Feedback System
por: Patel, Sajan, et al.
Publicado: (2022) -
Von Dashboards zu Dashboarding
por: Feldmann, Marc, et al.
Publicado: (2021) -
Efficacy and safety of iclepertin (BI 425809) in patients with schizophrenia: CONNEX, a Phase III randomised controlled trial programme
por: Falkai, P., et al.
Publicado: (2023)